Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
When Pam McClure learned she’d save nearly $4,000 on her prescription drugs next year, she said, “it sounded too good to be true.” She and her husband are both retired and live on a “very strict” budget in central North Dakota. By the end of this year, she will have spent almost $6,000 for her ...
Research shows about half of U.S. adults say they cannot afford their health care costs. According to an AARP Research study, healthcare affordability, rising health insurance costs and a lack of confidence in affording unexpected medical bills are significant concerns for adults ages 40 to 64.
There will be a major change to Medicare Part D in 2025 with the “doughnut hole,” or coverage gap going away. The maximum out-of-pocket cost for Part D prescriptions in 2025 will be $2,000.
In its estimates released Tuesday, CBO said 12.5 million Medicare beneficiaries would qualify for the medications beginning in 2026, and 2 percent would be expected to use the drugs in the first year.
Attention, Medicare Advantage enrollees: It’s a good idea to review your plans during open enrollment, which begins Tuesday, so you don’t get caught by surprise next year. Although the swiftly growing market remains stable overall, insurers are making a flurry of changes that could leave some senior citizens hunting for new policies, paying more out ...
The Centers for Medicare & Medicaid Services (CMS) rolled out guidance Oct. 2 as stakeholders prep for the second round of the drug price negotiation program. Made possible through the Inflation Reduction Act, the federal government has praised the program, saying it drastically lowers the cost of lifesaving drugs. The negotiation period for the first ...
Employers offering prescription drug benefits to their employees have an important annual duty: by October 14th each year, they must notify Medicare-eligible employees and their Medicare-eligible dependents whether their plan’s drug coverage is "creditable" or "non-creditable" as compared to a standard Medicare Part D drug plan.
Average premiums and benefits for Medicare’s prescription drug program and private Medicare plans are projected to remain stable in 2025 with premiums slightly declining, the Centers for Medicare and Medicaid Services said on Friday. WHY IT’S IMPORTANT The premiums are of interest to consumers enrolled in Medicare Advantage plans run by private insurers who are ...
The “vast majority” of the nation’s 67 million seniors eligible for Medicare health insurance won’t shop around for coverage options, let alone switch plans, a new analysis shows. KFF’s new research, which comes before open enrollment begins Oct. 15 for various Medicare coverage options for 2025 including Medicare Advantage, shows that 69% of those eligible Medicare beneficiaries did ...
Employers offering prescription drug benefits to their employees have an important annual duty: by October 14th each year, they must notify Medicare-eligible employees and their Medicare-eligible dependents whether their plan’s drug coverage is "creditable" or "non-creditable".